A new “hugely expensive” cholesterol drug does not improve overall survival chances for patients with heart disease and should be withdrawn from use, experts have said.
A coalition of doctors last night called on patients to be told that evolocumab, which was hailed as a “game changer” and “better than statins”, does nothing to prevent fatal heart attacks and strokes.
See http://www.telegraph.co.uk/news/2017/05/06/nhs-wasting-tens-thousands-year-wonder-drug-stroke-heart-attacks/ 
NHS wasting tens of thousands a year on ‘wonder’ drug for stroke and heart attacks which does not work, experts claim
A new “hugely expensive” cholesterol drug does not improve overall survival chances for patients with heart disease and should be withdrawn from use, experts have said.